Floatz logo

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine

Glioblastoma

Jonsson Comprehensive Cancer CentervaccinePhase 2Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
65/ 100

Competitive context

354 Active assets in the Glioblastoma cohort.

Asset / SponsorPhaseRating
Irinotecan
Beijing Sanbo Brain Hospital
Phase 2/3BBB
Depatuxizumab Mafodotin
AbbVie
Phase 3BB
CARMUSTINE
Leland Metheny
Phase 3BB
Irinotecan
University of Cincinnati
Phase 3BB
(+)-VINCRISTINE
University of Cincinnati
Phase 3BB

View all 50 →

Same molecule, other indications

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine is also rated in:

anaplastic astrocytomaDormant
B
Indicative ·
57 / 100
View asset →
anaplastic oligoastrocytomaDormant
B
Indicative ·
57 / 100
View asset →
gliomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →